Online citations, reference lists, and bibliographies.
Please confirm you are human
(Sign Up for free to never see this)
← Back to Search

Surface Loops Of Trypsin-like Serine Proteases As Determinants Of Function.

P. Goettig, H. Brandstetter, V. Magdolen
Published 2019 · Chemistry, Medicine

Save to my Library
Download PDF
Analyze on Scholarcy
Share
Trypsin and chymotrypsin-like serine proteases from family S1 (clan PA) constitute the largest protease group in humans and more generally in vertebrates. The prototypes chymotrypsin, trypsin and elastase represent simple digestive proteases in the gut, where they cleave nearly any protein. Multidomain trypsin-like proteases are key players in the tightly controlled blood coagulation and complement systems, as well as related proteases that are secreted from diverse immune cells. Some serine proteases are expressed in nearly all tissues and fluids of the human body, such as the human kallikreins and kallikrein-related peptidases with specialization for often unique substrates and accurate timing of activity. HtrA and membrane-anchored serine protease fulfill important physiological tasks with emerging roles in cancer. The high diversity of all family members, which share the tandem β-barrel architecture of the chymotrypsin-fold in the catalytic domain, is conferred by the large differences of eight surface loops, surrounding the active site. The length of these loops alters with insertions and deletions, resulting in remarkably different three-dimensional arrangements. In addition, metal binding sites for Na+, Ca2+ and Zn2+ serve as regulatory elements, as do N-glycosylation sites. Depending on the individual tasks of the protease, the surface loops determine substrate specificity, control the turnover and allow regulation of activation, activity and degradation by other proteins, which are often serine proteases themselves. Most intriguingly, in some serine proteases, the surface loops interact as allosteric network, partially tuned by protein co-factors. Knowledge of these subtle and complicated molecular motions may allow nowadays for new and specific pharmaceutical or medical approaches.
This paper references
10.1515/BC.2008.101
Reconstitution of human azurocidin catalytic triad and proteolytic activity by site-directed mutagenesis
M. Olczak (2008)
10.4049/jimmunol.1102205
Granzyme H of Cytotoxic Lymphocytes Is Required for Clearance of the Hepatitis B Virus through Cleavage of the Hepatitis B Virus X Protein
Haidong Tang (2012)
10.1074/jbc.M602372200
Specificity Profiling of Seven Human Tissue Kallikreins Reveals Individual Subsite Preferences*
M. Debela (2006)
10.1038/jid.2012.18
Kallikrein-related peptidase 8-dependent skin wound healing is associated with upregulation of kallikrein-related peptidase 6 and PAR2.
M. Kishibe (2012)
10.1007/s00418-018-1659-8
Tryptase as a polyfunctional component of mast cells
D. Atiakshin (2018)
10.1016/j.thromres.2017.10.008
An update on factor XI structure and function.
B. Mohammed (2018)
10.1074/JBC.M108131200
Molecular Determinants of the Mechanism Underlying Acceleration of the Interaction between Antithrombin and Factor Xa by Heparin Pentasaccharide*
N. Quinsey (2002)
10.1021/bi200878c
Crystallographic and kinetic evidence of allostery in a trypsin-like protease.
Weiling Niu (2011)
10.1515/hsz-2016-0205
Structural basis for the Zn2+ inhibition of the zymogen-like kallikrein-related peptidase 10
M. Debela (2016)
10.1111/j.1460-9568.2009.07029.x
A mental retardation gene, motopsin /neurotrypsin /prss12, modulates hippocampal function and social interaction
S. Mitsui (2009)
10.1042/BJ20151410
Combinatorial protein engineering of proteolytically resistant mesotrypsin inhibitors as candidates for cancer therapy.
I. Cohen (2016)
10.1111/j.1742-4658.2010.07638.x
Hepatocyte growth factor activator (HGFA): molecular structure and interactions with HGFA inhibitor‐1 (HAI‐1)
C. Eigenbrot (2010)
10.1016/S0969-2126(99)80125-7
Coagulation factor IXa: the relaxed conformation of Tyr99 blocks substrate binding.
K. Hopfner (1999)
10.1093/emboj/21.3.231
The crystal structure of the zymogen catalytic domain of complement protease C1r reveals that a disruptive mechanical stress is required to trigger activation of the C1 complex
M. Budayova-Spano (2002)
10.3324/haematol.2008.001867
Matriptase-2 (TMPRSS6): a proteolytic regulator of iron homeostasis
A. J. Ramsay (2009)
10.1111/j.1742-4658.2007.05756.x
Crystal structure of the catalytic domain of DESC1, a new member of the type II transmembrane serine proteinase family
O. J. Kyrieleis (2007)
10.1016/j.celrep.2012.02.012
The X-ray crystal structure of full-length human plasminogen.
R. Law (2012)
10.1111/jth.12849
Coagulation factor XII protease domain crystal structure
M. Pathak (2015)
10.1016/j.jmb.2008.01.089
Crystal structure of human epidermal kallikrein 7 (hK7) synthesized directly in its native state in E. coli: insights into the atomic basis of its inhibition by LEKTI domain 6 (LD6).
I. Fernández (2008)
10.1002/PROS.10191
Molecular cloning and expression of a variant form of hippostasin/KLK11 in prostate
T. Nakamura (2003)
Asp-70-->Lys mutant of factor X lacks high affinity Ca2+ binding site yet retains function.
A. Rezaie (1994)
10.1110/PS.9.5.859
Binding of Zn2+ to a Ca2+ loop allosterically attenuates the activity of factor VIIa and reduces its affinity for tissue factor
Lars C. Petersen (2000)
10.1073/PNAS.93.20.10653
Residue 225 determines the Na(+)-induced allosteric regulation of catalytic activity in serine proteases.
Q. Dang (1996)
10.1016/B978-0-12-382219-2.00584-6
Chapter 584 – Pancreatic Elastases
E. B. Oliveira (2013)
10.1074/JBC.M109830200
Catalytic Domain Structures of MT-SP1/Matriptase, a Matrix-degrading Transmembrane Serine Proteinase*
R. Friedrich (2002)
10.1038/NG1096-141
Hereditary pancreatitis is caused by a mutation in the cationic trypsinogen gene
D. Whitcomb (1996)
10.1038/nsmb1210
Factor B structure provides insights into activation of the central protease of the complement system
F. Milder (2007)
10.1042/BJ20130166
Zymogen activation of neurotrypsin and neurotrypsin-dependent agrin cleavage on the cell surface are enhanced by glycosaminoglycans.
Claudio Gisler (2013)
10.1038/35006683
Structural basis for the anticoagulant activity of the thrombin–thrombomodulin complex
P. Fuentes-Prior (2000)
10.1021/BI00811A022
Chymotrypsinogen: 2,5-Å crystal structure, comparison with α-chymotrypsin, and implications for zymogen activation
S. Freer (1970)
10.1016/J.CRVI.2004.07.011
Thrombin: A paradigm for enzymes allosterically activated by monovalent cations
E. Cera (2004)
10.1182/blood-2013-06-511733
Crystal structure of the prothrombinase complex from the venom of Pseudonaja textilis.
B. C. Lechtenberg (2013)
10.1016/B978-0-12-382219-2.00559-7
Introduction: Serine Peptidases and Their Clans
N. Rawlings (2013)
10.1016/j.thromres.2012.02.019
Tissue factor/factor VIIa complex: role of the membrane surface.
J. Morrissey (2012)
10.1073/PNAS.0402517101
Blarina toxin, a mammalian lethal venom from the short-tailed shrew Blarina brevicauda: Isolation and characterization.
Masaki Kita (2004)
10.2174/092986710791233706
Regulation of the protein C anticoagulant and antiinflammatory pathways.
A. Rezaie (2010)
10.1016/J.JMB.2007.03.011
A tick protein with a modified Kunitz fold inhibits human tryptase.
G. Paesen (2007)
10.1093/emboj/18.4.804
Structural basis of profactor D activation: from a highly flexible zymogen to a novel self‐inhibited serine protease, complement factor D
H. Jing (1999)
10.1016/B978-0-12-382219-2.00653-0
Chapter 653 – Polyserases
A. Moncada-Pazos (2013)
10.1371/journal.pone.0129511
The Importance of Exosite Interactions for Substrate Cleavage by Human Thrombin
Gurdeep Chahal (2015)
10.1021/BI00816A003
An effect of calcium ions on the activity, heat stability, and structure of trypsin.
T. Sipos (1970)
10.1016/B978-0-12-382219-2.00630-X
Chapter 630 – Complement Factor D
F. Forneris (2013)
10.1038/334528a0
The molecular evolution of genes and proteins: a tale of two serines
S. Brenner (1988)
10.1016/j.biochi.2015.09.002
The kallikrein-related peptidase family: Dysregulation and functions during cancer progression.
T. Kryza (2016)
10.1021/BC700328S
The synthesis and chelation chemistry of DOTA-peptide conjugates.
Luis M De León-Rodríguez (2008)
10.1016/0022-2836(74)90387-8
The structure of bovine trypsin : Electron density maps of the inhibited enzyme at 5 Å and at 2·7 Å resolution☆
R. Stroud (1974)
10.3390/ijms17121969
Effects of Glycosylation on the Enzymatic Activity and Mechanisms of Proteases
P. Goettig (2016)
10.1038/cddis.2017.487
Molecular motion regulates the activity of the Mitochondrial Serine Protease HtrA2
M. Merski (2017)
10.1124/pr.110.002733
Neutrophil Elastase, Proteinase 3, and Cathepsin G as Therapeutic Targets in Human Diseases
B. Korkmaz (2010)
10.1074/jbc.M115.675538
Kinetic Dissection of the Pre-existing Conformational Equilibrium in the Trypsin Fold*
Austin D. Vogt (2015)
10.1074/jbc.R116.737833
Molecular Mechanisms of Enzyme Activation by Monovalent Cations*
D. Gohara (2016)
10.1002/j.1460-2075.1996.tb01073.x
The 2.8 A crystal structure of Gla‐domainless activated protein C.
T. Mather (1996)
10.1074/JBC.M506051200
A True Autoactivating Enzyme
P. Gál (2005)
10.1515/BC.2000.150
Activation of proPHBSP, the Zymogen of a Plasma Hyaluronan Binding Serine Protease, by an Intermolecular Autocatalytic Mechanism
M. Etscheid (2000)
10.1016/j.jid.2016.10.015
Incomplete KLK7 Secretion and Upregulated LEKTI Expression Underlie Hyperkeratotic Stratum Corneum in Atopic Dermatitis.
S. Igawa (2017)
10.1002/1873-3468.13191
Crystal structure of plasma kallikrein reveals the unusual flexibility of the S1 pocket triggered by Glu217
Mingming Xu (2018)
10.1038/srep42341
Cockroach protease allergen induces allergic airway inflammation via epithelial cell activation
S. Kale (2017)
10.1016/B978-0-12-382219-2.00607-4
Human Kallikrein 1,Tissue Kallikrein
J. Chao (2013)
10.1074/jbc.RA118.004126
Blocking the proteolytic activity of zymogen matriptase with antibody-based inhibitors
Trine Tamberg (2018)
10.1515/bc.2010.037
Natural and engineered kallikrein inhibitors: an emerging pharmacopoeia
Joakim E. Swedberg (2010)
10.1038/nrd4534
Unleashing the therapeutic potential of human kallikrein-related serine proteases
I. Prassas (2015)
10.1016/j.ejphar.2015.04.045
Mast cell proteases as pharmacological targets.
G. Caughey (2016)
10.1016/0014-5793(89)80109-7
Cysteine proteases of positive strand RNA viruses and chymotrypsin‐like serine proteases
A. Gorbalenya (1989)
10.3390/molecules24010172
Click Chemistry as a Tool for Cell Engineering and Drug Delivery
Yukiya Takayama (2019)
10.1016/0022-2836(87)90658-9
Rat submaxillary gland serine protease, tonin. Structure solution and refinement at 1.8 A resolution.
M. Fujinaga (1987)
10.1074/jbc.273.42.27364
Definition and Redesign of the Extended Substrate Specificity of Granzyme B*
J. Harris (1998)
10.1074/jbc.272.48.29987
Evolutionary Divergence of Substrate Specificity within the Chymotrypsin-like Serine Protease Fold*
J. Perona (1997)
10.1146/annurev-cellbio-092910-154247
Membrane-anchored serine proteases in vertebrate cell and developmental biology.
R. Szabo (2011)
10.1038/srep31877
MASP-3 is the exclusive pro-factor D activator in resting blood: the lectin and the alternative complement pathways are fundamentally linked
J. Dobó (2016)
10.1080/09537100500123568
The interaction of thrombin with blood platelets
R. Lundblad (2005)
10.1016/S0969-2126(01)00203-9
The crystal structure of the catalytic domain of human urokinase-type plasminogen activator.
G. Spraggon (1995)
10.1155/2014/582842
Age-Related Macular Degeneration: Insights into Inflammatory Genes
R. Cascella (2014)
10.1111/jth.13339
Identification and functional characterization of a novel F5 mutation (Ala512Val, FVBonn) associated with activated protein C resistance
B. Pezeshkpoor (2016)
10.1016/j.biochi.2010.06.022
Natural and synthetic inhibitors of kallikrein-related peptidases (KLKs)
P. Goettig (2010)
10.1016/J.STR.2006.08.008
Structure of complement component C2A: implications for convertase formation and substrate binding.
F. Milder (2006)
10.1016/j.jmb.2011.10.007
Crystal structure of human prostate-specific antigen in a sandwich antibody complex.
E. Stura (2011)
10.1016/S1074-5521(01)00018-7
The three-dimensional structure of human granzyme B compared to caspase-3, key mediators of cell death with cleavage specificity for aspartic acid in P1.
J. Rotonda (2001)
10.4049/jimmunol.173.1.367
Human Complement Factor I Does Not Require Cofactors for Cleavage of Synthetic Substrates 1
Stefanos A. Tsiftsoglou (2004)
10.1016/j.bbagen.2013.11.017
Der p 1 is the primary activator of Der p 3, Der p 6 and Der p 9 the proteolytic allergens produced by the house dust mite Dermatophagoides pteronyssinus.
J. Herman (2014)
10.4049/jimmunol.0901141
MASP-1, a Promiscuous Complement Protease: Structure of Its Catalytic Region Reveals the Basis of Its Broad Specificity1
J. Dobó (2009)
10.1021/BI991130R
Crystal structure of the proenzyme domain of plasminogen.
E. Peisach (1999)
10.1515/hsz-2014-0140
Sweetened kallikrein-related peptidases (KLKs): glycan trees as potential regulators of activation and activity
Shihui Guo (2014)
10.1006/JMBI.2000.4343
Contribution of peptide bonds to inhibitor-protease binding: crystal structures of the turkey ovomucoid third domain backbone variants OMTKY3-Pro18I and OMTKY3-psi[COO]-Leu18I in complex with Streptomyces griseus proteinase B (SGPB) and the structure of the free inhibitor, OMTKY-3-psi[CH2NH2+]-Asp19
K. Bateman (2001)
10.1093/emboj/16.16.4797
Lysine 156 promotes the anomalous proenzyme activity of tPA: X‐ray crystal structure of single‐chain human tPA
M. Renatus (1997)
10.1007/s00018-008-7565-9
Serine peptidases: Classification, structure and function
M. Page (2008)
10.1111/J.1432-1033.1992.TB16916.X
The interaction of thrombin with fibrinogen. A structural basis for its specificity.
M. Stubbs (1992)
10.1016/j.febslet.2005.03.001
The anticoagulant protein C pathway
B. Dahlbäck (2005)
10.1038/cdd.2013.59
Mouse granzyme A induces a novel death with writhing morphology that is mechanistically distinct from granzyme B-induced apoptosis
O. Susanto (2013)
10.1016/j.str.2009.10.011
Structural basis of the cofactor- and substrate-assisted activation of human coagulation factor IXa.
Thomas Zögg (2009)
10.2174/138945009787846399
Mitochondrial serine protease HtrA2/Omi as a potential therapeutic target.
Md. Shenuarin Bhuiyan (2009)
10.1016/B978-0-12-382219-2.00592-5
Chapter 592 – γ-Tryptase
N. Trivedi (2013)
10.1074/JBC.272.33.20456
Optimal Subsite Occupancy and Design of a Selective Inhibitor of Urokinase*
S. Ke (1997)
10.3389/fonc.2018.00024
Multifaceted Role of the Urokinase-Type Plasminogen Activator (uPA) and Its Receptor (uPAR): Diagnostic, Prognostic, and Therapeutic Applications
Niaz Mahmood (2018)
10.1016/B978-0-12-382219-2.00590-1
Chapter 590 – Chymases
G. Caughey (2013)
10.1111/j.1365-2141.2011.08657.x
Function of the activated protein C (APC) autolysis loop in activated FVIII inactivation
T. J. Cramer (2011)
10.1038/nature01962
Staphylocoagulase is a prototype for the mechanism of cofactor-induced zymogen activation
R. Friedrich (2003)
10.1160/TH12-11-0840
Structure of plasma and tissue kallikreins.
M. Pathak (2013)
10.1016/B978-0-12-382219-2.00636-0
Complement Factor I
Robert B Sim (2013)
10.1021/PR060510D
Proteome-wide Identification of HtrA2/Omi Substrates.
L. Vande Walle (2007)
10.1074/jbc.M510096200
Substrate Specificity of Human Kallikrein 6
P. Angelo (2006)
10.1074/jbc.M509971200
High Resolution Structures of p-Aminobenzamidine- and Benzamidine-VIIa/Soluble Tissue Factor
S. P. Bajaj (2006)
10.3109/10408363.2013.865701
Function and clinical relevance of kallikrein-related peptidases and other serine proteases in gynecological cancers
J. Dorn (2014)
10.1111/j.1742-4658.2011.08351.x
Asparagine‐linked glycosylation of human chymotrypsin C is required for folding and secretion but not for enzyme activity
Melinda Bence (2011)
10.1016/j.bpc.2011.04.003
Rigidification of the autolysis loop enhances Na(+) binding to thrombin.
N. Pozzi (2011)
10.1371/journal.pone.0192661
Ligand binding modulates the structural dynamics and activity of urokinase-type plasminogen activator: A possible mechanism of plasminogen activation
T. Kromann-Hansen (2018)
10.1074/jbc.M801194200
Major Role of Human KLK14 in Seminal Clot Liquefaction*
Nashmil Emami (2008)
10.1074/jbc.M116.743237
Complex Formation of Human Proelastases with Procarboxypeptidases A1 and A2*
A. Szabó (2016)
10.1515/BC.2008.075
Structures and specificity of the human kallikrein-related peptidases KLK 4, 5, 6, and 7
M. Debela (2008)
10.1038/s41598-017-03457-7
Discovery of a novel conformational equilibrium in urokinase-type plasminogen activator
T. Kromann-Hansen (2017)
10.3390/ijms18071373
Profiling the Extended Cleavage Specificity of the House Dust Mite Protease Allergens Der p 1, Der p 3 and Der p 6 for the Prediction of New Cell Surface Protein Substrates
A. Jacquet (2017)
10.1016/J.JMB.2004.07.014
The structure of MBL-associated serine protease-2 reveals that identical substrate specificities of C1s and MASP-2 are realized through different sets of enzyme-substrate interactions.
V. Harmat (2004)
10.1074/jbc.270.38.22089
The Na+ Binding Site of Thrombin (*)
E. Di Cera (1995)
10.1371/journal.pone.0198644
A computational model for the evaluation of complement system regulation under homeostasis, disease, and drug intervention
Nehemiah T. Zewde (2018)
10.1093/nar/gkx1134
The MEROPS database of proteolytic enzymes, their substrates and inhibitors in 2017 and a comparison with peptidases in the PANTHER database
N. Rawlings (2018)
10.1016/j.biochi.2015.09.023
Kallikreins - The melting pot of activity and function.
Magdalena Kalińska (2016)
10.1074/jbc.M114.628560
Proteolytic Activation of the Protease-activated Receptor (PAR)-2 by the Glycosylphosphatidylinositol-anchored Serine Protease Testisin*
K. H. Driesbaugh (2014)
10.1021/pr500968d
Substrate specificities of the granzyme tryptases A and K.
K. Plasman (2014)
10.1038/s41598-018-19879-w
Novel mechanisms of Collagenase Santyl Ointment (CSO) in wound macrophage polarization and resolution of wound inflammation
Amitava Das (2018)
10.1210/jc.2014-3969
Human HtrA4 Expression Is Restricted to the Placenta, Is Significantly Up-Regulated in Early-Onset Preeclampsia, and High Levels of HtrA4 Cause Endothelial Dysfunction.
H. Singh (2015)
10.1038/32703
Human β-tryptase is a ring-like tetramer with active sites facing a central pore
P. Pereira (1998)
10.1016/j.jaci.2008.01.019
Chimerism, point mutation, and truncation dramatically transformed mast cell delta-tryptases during primate evolution.
N. Trivedi (2008)
10.1021/bi201203y
Plasmin substrate binding site cooperativity guides the design of potent peptide aldehyde inhibitors.
J. Swedberg (2011)
10.1373/CLINCHEM.2007.088104
Distribution of 15 human kallikreins in tissues and biological fluids.
J. Shaw (2007)
10.1002/PRO.5560060201
The internal thioester and the covalent binding properties of the complement proteins C3 and C4
S. Law (1997)
10.1126/science.1195821
Structures of C3b in Complex with Factors B and D Give Insight into Complement Convertase Formation
F. Forneris (2010)
10.1073/pnas.1616998114
Structure and activation of C1, the complex initiating the classical pathway of the complement cascade
S. Mortensen (2017)
10.1098/RSTB.1970.0010
Homologies in serine proteinases.
B. Hartley (1970)
10.1021/JA057721O
Subangstrom crystallography reveals that short ionic hydrogen bonds, and not a His-Asp low-barrier hydrogen bond, stabilize the transition state in serine protease catalysis.
C. N. Fuhrmann (2006)
10.1055/S-0038-1657577
Comparative analysis of haemostatic proteinases: structural aspects of thrombin, factor Xa, factor IXa and protein C.
W. Bode (1997)
10.1016/B978-0-12-382219-2.00562-7
Exfoliative Toxins – Staphylococcal Epidermolysins
G. Prévost (2013)
10.1073/pnas.201523798
The 2.0-Å crystal structure of tachylectin 5A provides evidence for the common origin of the innate immunity and the blood coagulation systems
N. Kairies (2001)
10.1042/BJ2900205
Evolutionary families of peptidases.
N. Rawlings (1993)
10.4049/jimmunol.1101381
Structural Insights into the Substrate Specificity of Human Granzyme H: The Functional Roles of a Novel RKR Motif
L. Wang (2012)
10.1074/jbc.M705190200
Activation Profiles and Regulatory Cascades of the Human Kallikrein-related Peptidases*
Hyesook Yoon (2007)
10.1016/B978-0-12-382219-2.00638-4
Prekallikrein and Plasma Kallikrein
A. Schmaier (2013)
10.1515/hsz-2014-0123
KLKs and their hormone-like signaling actions: a new life for the PSA-KLK family
M. Hollenberg (2014)
10.1016/j.archoralbio.2013.08.005
MMP20 and KLK4 activation and inactivation interactions in vitro.
Y. Yamakoshi (2013)
10.1515/bc.2010.055
Interdependence of kallikrein-related peptidases in proteolytic networks
Nathalie Beaufort (2010)
10.1055/S-0037-1614965
Thrombin-like Enzymes from Snake Venoms: An Updated Inventory On behalf of the Scientific and Standardization Committee’s Registry of Exogenous Hemostatic Factors
H. Pirkle (1998)
10.1016/B978-0-12-382219-2.00643-8
Chapter 643 – Thrombin
B. L. Bonniec (2013)
10.1097/01.mpa.0000232014.94974.75
Identification of CFTR, PRSS1, and SPINK1 Mutations in 381 Patients With Pancreatitis
Steven Keiles (2006)
10.1016/j.bbapap.2014.09.012
Proteoforms of the platelet-aggregating enzyme PA-BJ, a serine proteinase from Bothrops jararaca venom.
E. T. Yamashiro (2014)
10.1002/med.21451
Inhibitors of kallikrein‐related peptidases: An overview
N. Masurier (2018)
10.1073/pnas.0703714104
Chymotrypsin C (caldecrin) promotes degradation of human cationic trypsin: Identity with Rinderknecht's enzyme Y
R. Szmola (2007)
10.1016/J.BBAPAP.2007.11.012
1.2A-resolution crystal structures reveal the second tetrahedral intermediates of streptogrisin B (SGPB).
Ting-Wai Lee (2008)
10.1073/pnas.0707811104
Chymotryptic specificity determinants in the 1.0 Å structure of the zinc-inhibited human tissue kallikrein 7
M. Debela (2007)
10.1107/S0907444909000389
The structure of C2b, a fragment of complement component C2 produced during C3 convertase formation.
V. Krishnan (2009)
10.1021/ACSMEDCHEMLETT.6B00299
Buried Hydrogen Bond Interactions Contribute to the High Potency of Complement Factor D Inhibitors.
Chao-yie Yang (2016)
10.1016/j.mehy.2014.09.019
Human granzymes: related but far apart.
F. Vahedi (2014)
10.1016/j.chembiol.2014.08.013
Oral druggable space beyond the rule of 5: insights from drugs and clinical candidates.
B. Doak (2014)
10.1006/JMBI.1996.0376
Crystal structure of human trypsin 1: unexpected phosphorylation of Tyr151.
C. Gaboriaud (1996)
10.1016/0022-2836(72)90210-0
Structure of crystalline -chymotrypsin. V. The atomic structure of tosyl- -chymotrypsin at 2 A resolution.
J. Birktoft (1972)
10.1016/J.JMB.2006.08.003
Crystal structures of human tissue kallikrein 4: activity modulation by a specific zinc binding site.
M. Debela (2006)
10.1016/j.jmb.2007.11.052
Crystal structure of a ternary complex between human prostate-specific antigen, its substrate acyl intermediate and an activating antibody.
R. Ménez (2008)
10.1002/cphy.c100053
The kallikrein-kinin system as a regulator of cardiovascular and renal function.
N. Rhaleb (2011)
10.1515/hsz-2018-0122
Kallikrein-related peptidase 6 orchestrates astrocyte form and function through proteinase activated receptor-dependent mechanisms
Hyesook Yoon (2018)
10.1021/BI992006A
Sodium binding site of factor Xa: role of sodium in the prothrombinase complex.
A. Rezaie (2000)
10.1016/j.jchemneu.2011.05.014
Neuropsin—A possible modulator of synaptic plasticity
S. Shiosaka (2011)
10.1021/BI960656Y
Bovine thrombin complexed with an uncleavable analog of residues 7-19 of fibrinogen A alpha: geometry of the catalytic triad and interactions of the P1', P2', and P3' substrate residues.
P. Martin (1996)
10.1038/srep35385
Direct and indirect mechanisms of KLK4 inhibition revealed by structure and dynamics
B. T. Riley (2016)
10.1016/j.str.2009.09.014
Unraveling the allosteric mechanism of serine protease inhibition by an antibody.
Rajkumar Ganesan (2009)
10.1007/PL00006393
The Origin of Trypsin: Evidence for Multiple Gene Duplications in Trypsins
A. M. Baptista (1998)
10.1016/j.ajpath.2011.07.016
Kallikrein-related peptidase 14 acts on proteinase-activated receptor 2 to induce signaling pathway in colon cancer cells.
V. Gratio (2011)
10.1074/jbc.M113.459347
Residues of the 39-Loop Restrict the Plasma Inhibitor Specificity of Factor IXa*
L. Yang (2013)
10.1016/B978-0-12-382219-2.00602-5
Chapter 602 – Acrosin
I. Adham (2013)
10.1074/jbc.272.35.22037
Interaction of Calcium with Native and Decarboxylated Human Factor X.
A. Sabharwal (1997)
10.1016/j.molimm.2017.05.025
C1q: A fresh look upon an old molecule.
N. Thielens (2017)
10.1074/JBC.M401756200
Molecular Dissection of Na+ Binding to Thrombin*
A. Pineda (2004)
10.1002/PRO.5560060902
Crystal structures of bovine chymotrypsin and trypsin complexed to the inhibitor domain of alzheimer's amyloid β‐protein precursor (APPI) and basic pancreatic trypsin inhibitor (BPTI): Engineering of inhibitors with altered specificities
A. Scheidig (1997)
10.1042/BJ20100965
Proteases as therapeutics.
C. Craik (2011)
10.1038/s41598-018-29058-6
Structural determinants of specificity and regulation of activity in the allosteric loop network of human KLK8/neuropsin
M. Debela (2018)
10.1111/J.0022-202X.2004.23547.X
A proteolytic cascade of kallikreins in the stratum corneum.
M. Brattsand (2005)
10.1515/hsz-2014-0141
Differential expression of multiple kallikreins in a viral model of multiple sclerosis points to unique roles in the innate and adaptive immune response
M. Panos (2014)
10.1074/JBC.M504990200
Structural and Mutational Analyses of the Molecular Interactions between the Catalytic Domain of Factor XIa and the Kunitz Protease Inhibitor Domain of Protease Nexin 2*
D. Navaneetham (2005)
10.1515/BC.2009.026
A completed KLK activome profile: investigation of activation profiles of KLK9, 10, and 15
Hyesook Yoon (2009)
10.1016/j.toxicon.2008.05.013
A unique group of inactive serine protease homologues from snake venom.
J. Wu (2008)
10.1046/j.1538-7836.2003.00334.x
450 million years of hemostasis
C. J. Davidson (2003)
10.1158/1078-0432.CCR-18-1521
Harnessing Androgen Receptor Pathway Activation for Targeted Alpha Particle Radioimmunotherapy of Breast Cancer
D. Thorek (2018)
10.1021/PR0502065
Human plasma N-glycoproteome analysis by immunoaffinity subtraction, hydrazide chemistry, and mass spectrometry.
T. Liu (2005)
10.1016/0022-2836(74)90163-6
Structure of the complex formed by bovine trypsin and bovine pancreatic trypsin inhibitor. II. Crystallographic refinement at 1.9 A resolution.
R. Huber (1974)
10.1038/nsmb811
Structure of the antithrombin–thrombin–heparin ternary complex reveals the antithrombotic mechanism of heparin
W. Li (2004)
10.1016/0092-8674(87)90544-7
A family of serine esterases in lytic granules of cytolytic T lymphocytes
D. Masson (1987)
10.1189/jlb.0808495
Neutrophil‐derived azurocidin alarms the immune system
O. Soehnlein (2009)
10.1110/ps.800101
Enzyme specificity under dynamic control II: Principal component analysis of α‐lytic protease using global and local solvent boundary conditions
N. Ota (2001)
10.1021/BI00059A005
Structure of an engineered, metal-actuated switch in trypsin.
M. Mcgrath (1993)
10.1016/S0022-2836(02)00705-2
Crystal structure of a prostate kallikrein isolated from stallion seminal plasma: a homologue of human PSA.
A. Carvalho (2002)
10.1128/JB.178.20.5925-5929.1996
The DegP and DegQ periplasmic endoproteases of Escherichia coli: specificity for cleavage sites and substrate conformation.
H. Kolmar (1996)
10.1016/B978-0-12-382219-2.00671-2
Serine Endopeptidase Allergens from Dermatophagoides Species
T. Takai (2013)
10.1038/nri3839
Perforin and granzymes: function, dysfunction and human pathology
I. Voskoboinik (2015)
10.1016/S0022-2836(03)00849-0
Three dimensional structures of S189D chymotrypsin and D189S trypsin mutants: the effect of polarity at site 189 on a protease-specific stabilization of the substrate-binding site.
E. Szabó (2003)
10.1073/PNAS.92.21.9796
X-ray structure of clotting factor IXa: active site and module structure related to Xase activity and hemophilia B.
H. Brandstetter (1995)
10.1016/j.abb.2017.04.004
Structural insights into the activation mechanisms of human HtrA serine proteases.
D. Żurawa-Janicka (2017)
10.1111/jth.12950
Reincarnation of ancient links between coagulation and complement
E. Conway (2015)
10.1016/j.str.2012.03.021
Structural and functional analysis of HtrA1 and its subdomains.
C. Eigenbrot (2012)
10.1074/JBC.M011423200
Prostasin Is a Glycosylphosphatidylinositol-anchored Active Serine Protease*
L. Chen (2001)
10.1006/JMBI.1997.1306
Refined X-ray crystallographic structure of the poliovirus 3C gene product.
S. Mosimann (1997)
10.2174/1381612811319060003
HtrA protease family as therapeutic targets.
J. Skorko-Glonek (2013)
10.1016/j.tins.2014.05.007
Activity-controlled proteolytic cleavage at the synapse
P. Sonderegger (2014)
10.1038/nsmb.2013
Substrate-induced remodeling of the active site regulates human HTRA1 activity
Linda Truebestein (2011)
10.1523/JNEUROSCI.2542-12.2012
Processing of Neuregulin-1 by Neuropsin Regulates GABAergic Neuron to Control Neural Plasticity of the Mouse Hippocampus
Hideki Tamura (2012)
10.2147/IDR.S103101
Enzymatic degradation of in vitro Staphylococcus aureus biofilms supplemented with human plasma
C. Watters (2016)
10.1016/0009-9120(90)90601-P
Biochemical and biological aspects of the plasminogen activation system.
M. Mayer (1990)
10.1042/BST20150074
Creating functional sophistication from simple protein building blocks, exemplified by factor H and the regulators of complement activation.
Elisavet Makou (2015)
10.1074/jbc.M115.691097
A Single Glycan at the 99-Loop of Human Kallikrein-related Peptidase 2 Regulates Activation and Enzymatic Activity*
Shihui 世辉) Guo (郭 (2015)
10.1016/j.toxicon.2012.09.003
The long road of research on snake venom serine proteinases.
S. Serrano (2013)
10.1074/jbc.M600124200
Chymotrypsin C (Caldecrin) Stimulates Autoactivation of Human Cationic Trypsinogen*
Z. Nemoda (2006)
10.1091/MBC.E07-02-0124
LEKTI fragments specifically inhibit KLK5, KLK7, and KLK14 and control desquamation through a pH-dependent interaction.
C. Deraison (2007)
10.4049/jimmunol.167.2.1014
Interaction of Mite Allergens Der P3 and Der P9 with Protease-Activated Receptor-2 Expressed by Lung Epithelial Cells1
G. Sun (2001)
10.1021/BI015662V
Diverse stability and catalytic properties of human tryptase α and β isoforms are mediated by residue differences at the S1 pocket
T. Selwood (2002)
10.1016/B978-0-12-382219-2.00591-3
Human α-, β- and δ-Tryptases
N. Trivedi (2013)
10.1002/j.1460-2075.1996.tb00933.x
The 1.8 A crystal structure of human cathepsin G in complex with Suc‐Val‐Pro‐PheP‐(OPh)2: a Janus‐faced proteinase with two opposite specificities.
P. Hof (1996)
Enteropeptidase, a type II transmembrane serine protease.
X. Zheng (2009)
10.1074/JBC.274.7.4220
Crystal Structure of Neuropsin, a Hippocampal Protease Involved in Kindling Epileptogenesis*
Tadaaki Kishi (1999)
10.3324/haematol.2019.221093
Hemophilia A and B: molecular and clinical similarities and differences
G. Castaman (2019)
Elevated tumor tissue protein expression levels of kallikrein-related peptidases KLK10 and KLK11 are associated with a better prognosis in advanced high-grade serous ovarian cancer patients.
Xiaocong Geng (2018)
10.1007/s00281-017-0646-9
Auxiliary activation of the complement system and its importance for the pathophysiology of clinical conditions
M. Huber-Lang (2017)
10.2210/PDB6MV4/PDB
Sodium-site in serine protease domain of human coagulation factor IXa: evidence from the crystal structure and molecular dynamics simulations study.
K. Vadivel (2019)
10.1016/B978-0-12-382219-2.00560-3
Catalytic Mechanisms of Serine and Threonine Peptidases
L. Polgár (2013)
10.1038/214652A0
Three-dimensional Structure of Tosyl-α-chymotrypsin
B. Matthews (1967)
10.2741/2447
Hepsin and prostate cancer.
Q. Wu (2007)
10.1111/cea.12921
Cockroach allergen serine proteinases: Isolation, sequencing and signalling via proteinase‐activated receptor‐2
D. Polley (2017)
10.1111/j.1471-4159.2006.04105.x
Mesotrypsin, a brain trypsin, activates selectively proteinase‐activated receptor‐1, but not proteinase‐activated receptor‐2, in rat astrocytes
Y. Wang (2006)
10.2119/molmed.2010.00149
New Insights of an Old Defense System: Structure, Function, and Clinical Relevance of the Complement System
C. Ehrnthaller (2011)
10.1007/s00011-018-01210-y
Coevolution of the coagulation and immune systems
B. Arneth (2018)
10.1182/blood-2012-07-292094
In vivo roles of factor XII.
T. Renné (2012)
10.1074/jbc.R109.021006
Type II Transmembrane Serine Proteases*
Thomas H. Bugge (2009)
10.1021/acs.biochem.7b00340
Induced Fit Is a Special Case of Conformational Selection.
P. Chakraborty (2017)
10.1073/pnas.1200470109
NSP4, an elastase-related protease in human neutrophils with arginine specificity
N. C. Perera (2012)
10.1016/S0140-6736(03)13405-8
Haemophilias A and B
P. Bolton-Maggs (2003)
10.1042/BST20180211
Structural studies of plasmin inhibition.
Guojie Wu (2019)
10.1016/B978-0-12-385504-6.00002-6
Complex assemblies of factors IX and X regulate the initiation, maintenance, and shutdown of blood coagulation.
Thomas Zögg (2011)
10.1111/febs.13971
The role of type II transmembrane serine protease‐mediated signaling in cancer
Lauren M Tanabe (2017)
10.3389/fimmu.2016.00036
Early Components of the Complement Classical Activation Pathway in Human Systemic Autoimmune Diseases
Katherine E. Lintner (2016)
10.1007/s12016-018-8693-0
The Role of Dust Mites in Allergy
J. Miller (2018)
10.1371/journal.pone.0045956
HtrA3 as an Early Marker for Preeclampsia: Specific Monoclonal Antibodies and Sensitive High-Throughput Assays for Serum Screening
K. Dynon (2012)
10.1182/BLOOD.V104.11.1734.1734
Contribution of the 60 Loop To Substrate and Inhibitor Specificity of Thrombin.
A. Rezaie (2004)
10.1074/jbc.M114.598201
Structure-Function Analyses of Human Kallikrein-related Peptidase 2 Establish the 99-Loop as Master Regulator of Activity*
W. Skala (2014)
10.1038/srep17426
NES1/KLK10 gene represses proliferation, enhances apoptosis and down-regulates glucose metabolism of PC3 prostate cancer cells
J. Hu (2015)
10.1016/S0022-2836(02)00747-7
Crystal structures of uninhibited factor VIIa link its cofactor and substrate-assisted activation to specific interactions.
K. Sichler (2002)
10.1016/J.JMB.2007.08.042
Structural basis of the zinc inhibition of human tissue kallikrein 5.
M. Debela (2007)
10.1016/j.bpc.2008.02.012
Autolysis loop restricts the specificity of activated protein C: analysis by FRET and functional assays.
S. H. Qureshi (2008)
10.1007/s13238-012-2924-6
Complement genetics, deficiencies, and disease associations
K. R. Mayilyan (2012)
10.1007/978-1-4615-9543-4_80
Human urinary kallikrein--amino acid sequence and carbohydrate attachment sites.
J. Kellermann (1988)
10.1515/BC.2008.113
How Na+ activates thrombin – a review of the functional and structural data
J. Huntington (2008)
10.1517/14728222.2016.1147560
Kallikrein-related peptidases (KLKs) as emerging therapeutic targets: focus on prostate cancer and skin pathologies
M. Avgeris (2016)
10.1515/hsz-2018-0107
Specificity profiling of human trypsin-isoenzymes
O. Schilling (2018)
10.1042/BST0320021
Proteases of the complement system.
Robert B Sim (2004)
10.1160/TH04-12-0838
Tissue plasminogen activator in central nervous system physiology and pathology.
Jerry P. Melchor (2005)
10.1016/S0968-0004(01)02007-2
Evolution of enzyme cascades from embryonic development to blood coagulation.
M. Krem (2002)
10.1073/pnas.1718709115
Structure of the C1r–C1s interaction of the C1 complex of complement activation
Jamal O M Almitairi (2018)
10.1158/0008-5472.CAN-18-1745
Membrane-Anchored Serine Proteases and Protease-Activated Receptor-2-Mediated Signaling: Co-Conspirators in Cancer Progression.
Nisha R. Pawar (2019)
10.1126/SCIENCE.281.5383.1662
Crystal structure of the catalytic domain of human plasmin complexed with streptokinase.
X. Wang (1998)
10.3389/fcimb.2011.00005
Structure and Function of the Haemophilus influenzae Autotransporters
Nicole A. Spahich (2011)
10.1016/j.molimm.2011.04.004
Complement factor I in health and disease.
Sara C. Nilsson (2011)
10.1074/JBC.M409964200
The Critical Role of the 185–189-Loop in the Factor Xa Interaction with Na+ and Factor Va in the Prothrombinase Complex*
A. Rezaie (2004)
10.1111/j.1742-4658.2010.07659.x
Structures of human proteinase 3 and neutrophil elastase – so similar yet so different
Eric Hajjar (2010)
10.1080/14728222.2018.1512587
Kallikrein-related peptidases represent attractive therapeutic targets for ovarian cancer
D. Loessner (2018)
10.1515/hsz-2018-0148
Activation and activity of glycosylated KLKs 3, 4 and 11
Shihui Guo (2018)
10.32607/20758251-2017-9-2-17-33
Glutamyl Endopeptidases: The Puzzle of Substrate Specificity
I. Demidyuk (2017)
10.1016/S0022-2836(02)01337-2
Reconstructing the binding site of factor Xa in trypsin reveals ligand-induced structural plasticity.
Sabine Reyda (2003)
10.1073/pnas.1102167108
Structural basis for complement factor I control and its disease-associated sequence polymorphisms
P. Roversi (2011)
10.1016/S1097-2765(04)00160-1
Structural analysis of engineered Bb fragment of complement factor B: insights into the activation mechanism of the alternative pathway C3-convertase.
K. Ponnuraj (2004)
10.1002/prot.20368
1.70 Å X‐ray structure of human apo kallikrein 1: Structural changes upon peptide inhibitor/substrate binding
Gurunathan Laxmikanthan (2005)
10.1074/jbc.R109.027946
Functional Roles of Human Kallikrein-related Peptidases*
G. Sotiropoulou (2009)
10.1007/s00018-008-8502-7
Na+ binding to meizothrombin desF1
M. Papaconstantinou (2008)
10.1016/j.cub.2009.09.022
Convergent Evolution of Novel Protein Function in Shrew and Lizard Venom
Yael T. Aminetzach (2009)
10.1016/j.str.2014.07.008
Structures of neutrophil serine protease 4 reveal an unusual mechanism of substrate recognition by a trypsin-fold protease.
S. Lin (2014)
10.1515/hsz-2016-0177
Clinical relevance of kallikrein-related peptidase 6 (KLK6) and 8 (KLK8) mRNA expression in advanced serous ovarian cancer
N. Ahmed (2016)
10.1074/jbc.M114.551424
Corin Mutations K317E and S472G from Preeclamptic Patients Alert Zymogen Activation and Cell Surface Targeting*
N. Dong (2014)
10.1517/14728222.2010.487867
HtrA proteins as targets in therapy of cancer and other diseases
D. Żurawa-Janicka (2010)
10.1006/JMBI.1996.0238
The 2.3 A crystal structure of the catalytic domain of recombinant two-chain human tissue-type plasminogen activator.
D. Lamba (1996)
10.1016/B978-0-12-382219-2.00571-8
Chapter 571 – HtrA1 Peptidase
J. Chien (2013)
10.1002/jcb.22121
Identification of tubulins as substrates of serine protease HtrA1 by mixture‐based oriented peptide library screening
J. Chien (2009)
10.1074/jbc.M210722200
Physiological fIXa Activation Involves a Cooperative Conformational Rearrangement of the 99-Loop*
K. Sichler (2003)
10.3390/toxins9090290
A Review and Database of Snake Venom Proteomes
Theo Tasoulis (2017)
10.1016/j.thromres.2012.07.023
The Marburg I polymorphism of factor VII activating protease is associated with low proteolytic and low pro-coagulant activity.
M. Etscheid (2012)
10.1111/jth.13194
The contact activation and kallikrein/kinin systems: pathophysiologic and physiologic activities
A. Schmaier (2016)
10.1074/jbc.271.28.16614
Autoproteolysis or Plasmin-mediated Cleavage of Factor Xaα Exposes a Plasminogen Binding Site and Inhibits Coagulation*
E. L. Pryzdial (1996)
10.1074/jbc.M703202200
Important Role of the Cys-191–Cys-220 Disulfide Bond in Thrombin Function and Allostery*
Leslie A. Bush-Pelc (2007)
10.1016/B978-0-12-382219-2.00569-X
Chapter 569 – DegP Protease
Niklas Weber (2013)



This paper is referenced by
Semantic Scholar Logo Some data provided by SemanticScholar